NOVAVAX INC's ticker is NVAXXXXX and the CUSIP is 670002104. A total of 153 filers reported holding NOVAVAX INC in Q4 2014. The put-call ratio across all filers is 6.66 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $26,000 | -76.6% | 20,258 | -62.0% | 0.00% | -100.0% |
Q3 2016 | $111,000 | -71.1% | 53,319 | +0.8% | 0.00% | -50.0% |
Q2 2016 | $384,000 | +141.5% | 52,900 | +72.1% | 0.01% | +200.0% |
Q1 2016 | $159,000 | -78.0% | 30,734 | -64.3% | 0.00% | -75.0% |
Q4 2015 | $723,000 | +67.0% | 86,100 | +40.6% | 0.01% | +100.0% |
Q3 2015 | $433,000 | +230.5% | 61,234 | +424.1% | 0.00% | +100.0% |
Q2 2015 | $131,000 | +27.2% | 11,683 | -6.4% | 0.00% | +100.0% |
Q1 2015 | $103,000 | -92.0% | 12,479 | -94.2% | 0.00% | -85.7% |
Q4 2014 | $1,283,000 | -67.4% | 216,410 | -77.1% | 0.01% | -63.2% |
Q3 2014 | $3,934,000 | +1144.9% | 943,436 | +1280.9% | 0.02% | +1800.0% |
Q2 2014 | $316,000 | +225.8% | 68,320 | +220.0% | 0.00% | – |
Q1 2014 | $97,000 | -59.1% | 21,347 | -54.0% | 0.00% | -100.0% |
Q4 2013 | $237,000 | – | 46,447 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BB BIOTECH AG | 8,330,000 | $10,496,000 | 0.39% |
Alden Global Capital LLC | 640,500 | $807,000 | 0.28% |
Quantitative Investment Management, LLC | 3,784,100 | $4,767,000 | 0.12% |
Eventide Asset Management | 1,449,700 | $1,827,000 | 0.12% |
Bellevue Group AG | 325,000 | $410,000 | 0.08% |
Virtus ETF Advisers LLC | 196,162 | $247,000 | 0.07% |
Rock Springs Capital Management LP | 820,000 | $1,033,000 | 0.07% |
Quantbot Technologies LP | 462,250 | $582,000 | 0.06% |
Traynor Capital Management, Inc. | 43,361 | $55,000 | 0.04% |
Tekla Capital Management LLC | 571,000 | $719,000 | 0.03% |